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Prognosis for breast cancer patients has improved over the past
few decades; relative 10-year survival rates increased from 47%
for patients diagnosed in 1970–1974 to 61% for patients diagnosed
in 1980–1984 (Nab et al, 1994a). Studies in the UK, Sweden, New
Zealand, and The Netherlands found that about 20 years after 
diagnosis the life expectancy of patients with breast cancer resem-
bles that of the general population (Brinkley and Haybittle, 1975;
Hibberd et al, 1983; Rutqvist and Wallgren, 1985; Fentiman et al,
1994; Nab et al, 1994b), suggesting that patients can then be
considered cured. However, breast cancer recurrences or meta-
stases may develop decades after initial diagnosis and treatment
(Hibberd et al, 1983; Nab et al, 1994b) and a higher death rate due
to breast cancer has been reported up to 40 years after diagnosis
(Rutqvist and Wallgren, 1985). 
Since the age-adjusted incidence rate in Southeast Netherlands,
as in many other Western countries, has doubled since 1960 (Nab
et al, 1993) and prognosis has improved, the number of long-term
survivors of breast cancer has increased markedly. However, it
remains unclear whether these patients should still be considered
at increased risk of being affected by breast cancer, even though
this is important for follow-up surveillance and the natural history
of breast cancer. 
In the present population-based study, we investigated mortality
of breast cancer patients who had survived at least 10 years after
diagnosis, comparing this with that of the general population by
calculating standardized mortality ratios (SMRs). 
METHODS 
Data on diagnosis, stage of disease, and treatment were obtained from
the population-based Eindhoven Cancer Registry, which has collected
data on new cancer patients since 1955 according to international
guidelines (Parkin et al, 1997). The registry covers an area of
2500 km2 in Southeast Netherlands with a population of almost one
million inhabitants. The data on first and second primary breast
tumours were obtained, after notification by pathologists, from
pathology reports, hospital records, and the regional Radiotherapy
Institute. Access to specialized care was good during the whole
period. 
Medical registration of causes of death in the Netherlands is
similar to that in many other countries, according to WHO guide-
lines. The attending physician must report the underlying cause of
death. Statistics Netherlands assigns a code for the underlying
cause of death according to the International Classification of
Diseases, ninth revision (ICD-9) (World Health Organisation,
1977). If any other medically relevant information is mentioned on
the death certificate, the secondary cause of death is also recorded.
The anonymous cause-of-death register, maintained by Statistics
Netherlands, is listed per municipality according to sex and age
(derived from date of birth and date of death). 
Patients were tracked by the Central Bureau of Genealogy in
order to obtain the unique death certificate number. Statistics
Netherlands was provided with a list, according to municipality of
death, the date of birth, date of death and death certificate number
(when available). The data were obtained at an aggregate level fit
for data analysis. 
All 1460 patients diagnosed with breast cancer in 1960 through
1979 who survived at least 10 years after initial diagnosis were
selected for the present study. Follow-up was completed until
1.1.1994, when 487 long-term survivors had died. The causes of
death of those patients who survived at least 10 years but died in
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1970–1979 (n = 47) were not traced, because of the high search
costs per year and the low yield. For 22 patients the cause of death
could not be traced. Consequently, observed causes of death are
presented only for 418 patients. 
In the analysis, intervals of follow-up (10–14, 15–19 and 20
years or more) were distinguished. Causes of death were grouped
together according to major disease categories. SMRs were calcu-
lated for comparison of causes of death in the study population
with the general female population. In this person-years type of
analysis, the ratio of the observed (O) and expected (E) numbers of
deaths was determined. Time at risk began at the date of diagnosis
and ended at the date of death or the end of the follow-up period
(1.1.1994), whichever occurred first. Taking into account the
person-years of observation in the cohort (by age and calendar
period), expected numbers of death were computed using age-,
and calendar-period-specific cancer death rates from the area of
the Eindhoven Cancer Registry. The confidence limits of SMR
were obtained with the use of the Poisson distribution of observed
numbers (Pearson and Hartley, 1976). SMRs were calculated for
all patients together and separately by follow-up interval. 
RESULTS 
Clinical characteristics are presented in Table 1 according to
period of diagnosis. Adjuvant primary radiotherapy was adminis-
tered to 53% of patients with localized tumours and 84% of those
with regional or distant disease. Only 11 patients received adjuv-
ant systemic therapy, 9 of whom had regional or distant disease at
the time of diagnosis, one had a T4 tumour and in one patient
tumour stage was unknown. 
Of all 418 patients surviving for at least 10 years after diagnosis
196 (47%) died from breast cancer and 50 (12%) from another
cancer (Table 2). In another 13 cases breast cancer was recorded as
secondary cause of death. 
Among those who survived 10–14 years after initial diagnosis
the observed number of total deaths was higher than expected
(SMR: 1.3; 95% CI: 1.1–1.5) (Table 3). The risk of dying from
breast cancer was almost 16 times higher than expected
(13.1–18.8). In the patients who survived 15–19 years the SMR for
all causes of death was 1.0, with an excess risk of dying from
breast cancer (SMR: 11.0; 95% CI: 8.3–14.3). For those patients
surviving more than 20 years the observed number of total deaths
was lower than expected (SMR: 0.6; 95% CI: 0.4–0.7), but the risk
of dying from breast cancer was still almost 5 times higher than
expected (95% CI: 2.6–7.8). 
The distribution of patients dying from cancer other than breast
cancer is shown in Table 4. High, but not statistically significant,
SMRs were observed for small bowel and brain tumours and low
SMRs for cancer of the stomach, larynx and lung. Another cancer
Table 1 Characteristics of 418 deceased breast cancer patients diagnosed in 1960–1979 who survived at least 10 years 
Period of diagnosis 
1960–1969 n (%) 1970–1979 n (%) Total n (%) 
Age at diagnosis (yrs) 
<40 6 (7.8) 16 (4.7) 22 (5.3) 
40–49 21 (27) 58 (17) 79 (19) 
50–59 21 (27) 83 (24) 104 (25) 
60–69 21 (27) 117 (34) 138 (33) 
³ 70 8 (10) 67 (20) 75 (18) 
Tumour stage 
Local 42 (55) 168 (49) 210 (50) 
Regional 34 (44) 121 (36) 155 (37) 
Distant 0 (0) 4 (1.2) 4 (1.0) 
Unknown 1 (1.3) 48 (14) 49 (12) 
Histological type 
Ductal 49 (64) 300 (88) 349 (84) 
Lobular 2 (2.6) 12 (3.5) 14 (3.3) 
Mucinous 1 (1.3) 9 (2.6) 10 (2.4) 
Medullar 2 (2.6) 6 (1.8) 8 (1.9) 
Sarcoma 1 (1.3) 0 (0) 1 (0.2) 
Not otherwise specified 22 (29) 14 (4.1) 36 (8.6) 
Radiotherapy 
No 17 (22) 144 (42) 161 (39) 
Yes 60 (78) 197 (58) 257 (61) 
Total (% of study population) 77 (13) 341 (87) 418 (100) 
Table 2 Causes of death in breast cancer patients surviving for more than
10 years after diagnosis in 1960–1979 for different intervals of follow-up 
10–14 yrs 15–19 yrs ³20 yrs Total 
n (%) n (%) n (%) n (%) 
Cause of death 
Breast cancer 126 (54) 56 (42) 14 (27) 196 (47) 
Other cancer 23 (9.7) 17 (13) 10 (20) 50 (12) 
Cardiovascular disease 53 (22) 36 (27) 17 (33) 106 (25) 
Respiratory disease 7 (3.0) 3 (2.2) 4 (7.8)  14 (3.3) 
Disease of the digestive 
system 4 (1.7) 3 (2.2)  3 (1.3) 10 (2.4) 
External causesa 6 (2.5) 4 (3.1) –  10 (2.4) 
Other causes 16 (6.8) 13 (10) 3 (1.3) 32 (7.6) 
Total (% of study population) 235 (56) 132 (32) 51 (12) 418 (100) 
aIncludes accidents, murder, suicide. 702 WJ Louwman et al 
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was the secondary cause of death for another 9 patients, of whom 4
had female genital cancer. 
Patients who died from breast cancer after 10 years were gener-
ally younger at diagnosis and at death than those who died from
other causes (Table 5). Among patients with localized disease the
proportion who died from breast cancer equalized to the propor-
tion dying from other causes, until 20 years after diagnosis.
Patients diagnosed with regional disease were more likely to die
from breast cancer 10–14 years after diagnosis, whereas the
proportion dying from other causes became higher thereafter. 
A second primary breast tumour was present in 131 of the 1460
patients (9%). For 76 women with a second breast tumour the
cause of death was unknown because the patients were still alive at
1.1.94 (n = 67), died between 1970 and 1979 (n = 5), or the cause
of death could not be traced (n = 4). For 55 patients with a second
breast tumour the cause of death was known: 39 (71%) died from
breast cancer and 16 died from other causes. 
DISCUSSION 
Breast cancer patients who have survived 20 years or more after
diagnosis and are presumed to have a normal life expectancy were
still at a 5-fold increased risk of dying from breast cancer.
Mortality from other causes was lower. 
Registration of cause of death in the Netherlands is similar to
that in other countries, according to WHO guidelines. Could over-
reporting of breast cancer as the underlying cause of death explain
the excess death risk? We think that rather this tendency, if
present, declines with the duration of follow-up. Breast cancer
would tend only to be reported if there was clear progression in
the disease or a second breast cancer had occurred. We found that
in 39 (71%) of the 55 patients who had developed a second
primary breast tumour, the death was attributed to breast cancer.
Fentiman et al (1994) found that 10% of patients surviving more
than 20 years since diagnosis of the first tumour died from meta-
stases from contralateral cancer and late deaths from breast cancer
were due to new tumours rather than a late manifestation of slow-
growing metastases. Of the 51 such patients in our study, 11
(22%) developed a second breast tumour, 7 of whom died from
the disease. A total of 14 long-term survivors died from breast
cancer (Table 2). So if the 7 deaths in those with a second primary
tumour were caused by this second tumour, the other 7 deaths due
to breast cancer (50%) resulted from progression of the initial
disease. 
Irrespective of whether late death from breast cancer was due to
metastasis from the initial tumour or from a second primary, the
question remains whether excess death from breast cancer can be
prevented by longer regular surveillance or better treatment. Routine
follow-up by physical examination and an annual or biannual
mammography would be sufficient to detect recurrences or a second
primary tumour (Rutgers et al, 1989). More importantly, overall
mortality in patients who survived over 20 years after initial dia-
gnosis became lower than in the general population. Even if those
deceased patients of whom the cause of death was not traced (n= 69)
were added to the observed number of deaths the SMRs for overall
mortality remained roughly the same (SMR: 1.5, 1.1, and 0.7 for
those surviving 10–14 years, 15–19, and ³20 years, respectively). 
Patients diagnosed before the age of 50 were more likely to die
from breast cancer than from other causes. Proportional mortality
from breast cancer is clearly related to age at death (Philips et al,
1999). At younger ages women are less likely to die from other
causes, so that the proportion dying from breast cancer is relatively
high. We took account of this by calculating standardized mortality
rates, but breast cancer mortality remained higher than expected.
We also checked whether misclassification of cause of death in the
oldest elderly may have affected the high death rates from breast
cancer. However, we found that the percent of patients who died
from breast cancer was actually lower in the 85+ group than in the
total study-population. 
Table 3 Number of observed (O) and expected (E) causes of death, standardized mortality ratios (SMRs) and 95% CI in breast cancer patients for different
intervals of follow-up 
10–14 years 15–19 years ³ 20 years 
O E SMR (95% CI) O E SMR (95% CI) O E SMR (95% CI) 
Cause of death 
Breast cancer 126 8.0 15.8 (13.1–18.8)  56 5.1 11.0 (8.3–14.3) 14 3.0 4.7  (2.6–7.8) 
Other cancer 23 32.2 0.7 (0.5–1.1) 17 21.6 0.8 (0.5–1.3) 10 13.4 0.7 (0.4–1.4) 
Cardiovascular disease 53 89.2 0.6 (0.4–0.8) 36 64.6 0.6 (0.4–0.8) 17 44.2 0.4 (0.2–0.6) 
Respiratory disease 7 11.7 0.6 (0.2–1.2) 3 9.7 0.3 (0.1–0.9) 4 7.3  0.5 (0.1–1.4) 
Other causes 26 39.5 0.7 (0.4–1.0) 20 32.2 0.6 (0.4–1.0) 6 24.0 0.3 (0.1–0.5) 
Total 235 180.7 1.3 (1.1–1.5) 132 133.1 1.0 (0.8–1.2) 51 91.9 0.6 (0.4–0.7) 
Table 4 Number observed (O) and expected (E), standardized mortality
ratios (SMR), and 95% CI for breast cancer patients who survived ³ 10 years
and died from cancer other than breast cancer 
O E SMR (95% CI) 
Tumour site (ICD-codes) 
Head, Neck, Oesophagus (140–150) 1 1.6 0.6  (0.0–3.5) 
Stomach (151) 3 7.3 0.4 (0.1–1.2) 
Small bowel (152) 2 0.3 6.1 (0.8–24) 
Colon, Rectum (153, 154) 10 14.2 0.7 (0.3–1.3) 
Liver, Biliary tract, Pancreas (155–157) 5 8.2  0.6 (0.2–1.4) 
Larynx, Lung (161, 162) 2 5.2 0.4 (0.0–1.4) 
Cervix uteri (180) 1 1.2 0.8 (0.0–4.6) 
Corpus uteri (182) 1 1.6 0.6 (0.0–3.5) 
Ovary (183) 6 4.6 1.3 (0.5–2.8) 
Urinary tract (188, 189) 4 4.2 0.9 (0.3–2.4) 
Brain (191) 2 0.7 2.7 (0.3–10) 
Haemopoietic (200–208) 6 6.7 0.9 (0.3–2.0) 
Other malignancies 7 11.4 0.6 (0.2–1.3) 
Total 50 67.3 0.7 (0.6–1.0) Cause of death in long term survivors of breast cancer 703
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The pattern of death due to cancer other than breast cancer was
not very surprising. The increased observed/expected ratio for
small bowel cancer could also be a random finding. Increased risks
after breast cancer, regularly reported for cancer of the colon-
rectum, ovary, and uterus (Schenker et al, 1984; Ewertz and
Mouridsen, 1985; Harvey and Brinton, 1985; Teppo et al, 1985;
Rutqvist et al, 1995) are partly explained by a common aetiology
or pathogenesis (e.g., hormonal exposure or susceptibility). The
decreased risk for tobacco-related cancers in the lung and head and
neck area could also be related to the high socio-economic status
of breast cancer patients (Schrijvers et al, 1997), greater health
awareness could also play a role. 
Previously, excess mortality from breast cancer despite a normal
life-expectancy was also observed in British women diagnosed
between 1947 and 1950 who survived more than 20 years
(Brinkley and Haybittle, 1975, 1984). The present study indicates
that these findings are still valid for patients diagnosed in later
decades (1960–1979). Despite a normal (or even improved) life
expectancy for breast cancer patients 20 years after diagnosis, the
risk of dying from this disease remained elevated. 
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